öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÍõÓÀ»ª
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º629

ËùÊôԺУ£ºÊ¯ºÓ×Ó´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Ñ§
Ñо¿ÁìÓò£º ϵͳҩÀíѧ¡¢
Ñо¿ÁìÓò£º ϵͳҩÀíѧ¡¢ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£º**@qq.com


¸öÈ˼òÊö :
ÍõÓÀ»ª£¬ÄУ¬ÉúÓÚ1973Äꣻ¼®¹á£¬Öйú´óÁ¬£»ÕþÖÎÃæò£¬ÈºÖÚ£»Ö°³Æ£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£

¿ÆÑгɹû

Ãû³Æ

Àà±ð

ʱ¼ä

µÈ¼¶

ÅÅÃû

ÒÔ¹ðÖ¦ÜòÜß½ºÄÒΪʾ·¶µÄÖгÉÒ©¹¦Ð§Ïà¹ØÖÊÁ¿¿ØÖÆÌåϵ´´Á¢¼°Ó¦ÓÃ

¹ú¼Ò¿Æ¼¼½ø²½½±

2015Äê

¶þµÈ½±

ÖÐÒ½Ö¤ºòÎïÖÊ»ù´¡ÓëÖÐÒ©¹¦Ð§·Ö×ÓÍøÂç°ÐµãÉúÎïϵͳѧ½âÎö

ɽ¶«Ê¡×ÔÈ»¿Æѧ½±

2014Äê

¶þµÈ½±

רÀûÇé¿ö

רÀûÃû³Æ

רÀûÀàÐÍ

ÊÚÓèʱ¼ä

ßÁàºÀ໯ºÏÎï¡¢ÆäÖƱ¸·½·¨¼°º¬ÓÐËüÃǵÄÒ©Îï×éºÏÎï

2014.4

ÓÃÓÚÖÎÁÆ·ÇСϸ°û·Î°©µÄÒ©Îï×éºÏÎï¼°ÆäÓ¦ÓÃ

2014.4


¿ÆÑй¤×÷ :
»ù½ðÏîÄ¿£º¹ú¼Ò»ù½ðµØÇøÖصãÁªºÏ»ù½ð¡ª¡ªÎ¬Ò©¸´·½Î÷ºì»¨ÖÎÁƹÚÐIJ¡·Ö×Ó»úÖÆÑо¿¡£

ÍŶÓÔÚÑÐÏîÄ¿3Ï

1£©Ã«¾ÕÜÄ»îÐԳɷֿ¹¸ÎÏËά»¯·Ö×Ó»úÖƼ°Æ乹Ч¹ØϵÑо¿£¨µØÇø¿Æѧ»ù½ðÏîÄ¿H2814£©2016.1-2019.12£¬ÍòÔª£¬Ö÷³ÖÈË£ºÇض¬Ã·

2£©»ùÓÚ³¦µÀ¾úȺºÍ´úл×éѧµÄ¡°Î÷ÅÁÒÀÀ£½á°²-¶ÌÁ´Ö¬·¾ËᡱЭͬ×÷ÓûúÖÆÑо¿£¨µØÇø¿Æѧ»ù½ðÏîÄ¿H2818£©2016.1-2019.12£¬46.8ÍòÔª£¬Ö÷³ÖÈË£ºº«²©

3£©À£½á°²-¶ÌÁ´Ö¬·¾ËḴ·½µÄÁÙ´²Ç°Ñо¿£¬±øÍÅÉç»á·¢Õ¹¿Æ¼¼¹¥¹ØÓë³É¹ûת»¯¼Æ»®2015AD002£¬30.00ÍòÔª£¬Ö÷³ÖÈË£ºº«²©
ϵͳҩÀíѧ

ѧ»áÃû³Æ

µ£(¼æ)ÈεÄÖ°Îñ

ʱ ¼ä

ѧÊõ¿¯ÎïMircroRNA

¸±Ö÷±à

2013ÄꡪÖÁ½ñ

ѧÊõ¿¯ÎïJournalofBioequivalence&Bioavailability

±àί

2013ÄꡪÖÁ½ñ

ѧÊõ¿¯ÎïCurrent Pharmaceutical Design

¿Í×ù±à¼­

2014¡ªÖÁ½ñ

Journal of Intercultural Ethnopharmacology

¿Æѧ¹ËÎÊÍųÉÔ±

2013ÄꡪÖÁ½ñ

ÊÀ½çÖÐҽҩѧ»áÖÐÒ©ÁªºÏ»á

µÚ¶þ½ìÀíÊ»áÀíÊÂ

2013ÄꡪÖÁ½ñ

ÊÀ½çÖÐҽҩѧ»áÖÐÒ©Ò©ÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á

ίԱ

2013ÄꡪÖÁ½ñ

ÃÀ¹ú»¯Ñ§»á

»áÔ±

2013ÄꡪÖÁ½ñ

ÉÂÎ÷Ê¡¿Æ¼¼½±ÀøÆÀÉóר¼Ò

ÆÀÉóר¼Ò

2014¡ªÖÁ½ñ

¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÆÀÉóר¼Ò

ÆÀÉóר¼Ò

ɽ¶«Ê¡¿Æ¼¼½±ÀøÆÀÉóר¼Ò

ÆÀÉóר¼Ò

ºÓÄÏÖÐҽѧԺ·Î²¡ÖÐÒ©·ÀÖθÚλ¿Æѧ¼Ò
¸öÈË·¢±íÂÛÎÄ7ƪ£º

1£©Pei T, Zheng C, Huang C, Chen X, Guo Z, Fu Y, Liu J, Wang Y*.Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. J Ethnopharmacol. 2016 Jun 2. pii: S0378-8741(16)30353-1. doi: 10.1016/j.jep.2016.06.001.

2£©Zheng C, Pei T, Huang C, Chen X, Bai Y, Xue J, Wu Z, Mu J, Li Y, Wang Y*.A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease. Eur J Pharm Sci. 2016 May 18. pii: S0928-0987(16)30187-7. doi: 10.1016/j.ejps.2016.05.018.

3£©Liu J, Pei T, Mu J, Zheng C, Chen X, Huang C, Fu Y, Liang Z, Wang Y*.Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever. Evid Based Complement Alternat Med. **:**. doi: 10.1155/2016/**. Epub 2016 Apr 27.

4£©Zhang W, Bai Y, Wang Y*, Xiao W.Polypharmacology in drug discovery: a review from systems pharmacology perspective. Curr Pharm Des. 2016 Feb 24.

5£©Zhang B, Fu Y, Huang C, Zheng C, Wu Z, Zhang W, Yang X, Gong F, Li Y, Chen X, Gao S, Chen X, Li Y, Lu A, Wang Y*.New strategy for drug discovery by large-scale association analysis of molecular networks of different species.Sci Rep. 2016 Feb 256:21872. doi: 10.1038/srep21872.

6£©Jinan Wang, Zihu Guo, Yingxue Fu, Ziyin Wu, Chao Huang,Chunli Zheng, Piar Ali Shar, Zhenzhong Wang, Wei Xiao, Yonghua Wang*.Weak-binding molecules are not drugs?¡ªtoward a systematic strategy for finding effective weak-binding drugs, Briefings in Bioinformatics, 2016, 2016

7£©Shar PA, Tao W, Gao S, Huang C, Li B, Zhang W, Shahen M, Zheng C, Bai Y, Wang Y*.Pred-binding: large-scale protein-ligand binding affinity prediction.J Enzyme Inhib Med Chem. 2016 Feb 18:1-8.

Öø×÷³ö°æ£ºÍõÓÀ»ª½ÌÊÚ±àдÁË¡¶ÏµÍ³Ò©ÀíѧԭÀí¡¢·½·¨¼°Ó¦Óá·Öø×÷£¬ÓÉ´óÁ¬Àí¹¤³ö°æÉç³ö°æ£¬2016Äê4ÔµÚÒ»°æ£¬ÎªÏµÍ³Ò©ÀíѧµÄÑо¿¼°¹¤×÷µÄ¿ªÕ¹ÌṩÁËÀíÂÛ¼°¼¼ÊõµÄÖ¸µ¼¡£
2009.8-ÖÁ½ñ£¬Î÷±±Å©ÁֿƼ¼´óѧ£¬½ÌÊÚ£»

2003.8-2009.7£¬´óÁ¬º£Ñó´óѧ£¨´óÁ¬Ë®²úѧԺ£©£¬¸±½ÌÊÚ£»

2000.1-2000.8£¬Òâ´óÀû¶¼ÁéÀí¹¤´óѧ£¬·ÃÎÊѧÕߣ»

1997.8-2000.7£¬Öйúº£ÑóʯÓ͹«Ë¾£¬¹¤³Ìʦ¡£


½ÌÓý±³¾° :
2000.8-2006.8£¬ÖпÆÔº´óÁ¬»¯Ñ§ÎïÀíÑо¿Ëù£¬Ë¶²©Á¬¶Á£»

1993.9-1997.7£¬´óÁ¬Àí¹¤´óѧ£¬±¾¿Æ¡£

2000.1-2000.8£¬Òâ´óÀû¶¼ÁéÀí¹¤´óѧ£¬·ÃÎÊѧÕߣ»